Changzhou Ruiming Pharmaceutical: Driven by scientific and technological innovation, it helps a new chapter in diabetes treatment

Under the severe challenge of diabetes as a global health problem, Changzhou Ruiming Pharmaceutical Co., LTD. (hereinafter referred to as "Ruiming Pharmaceutical") is gradually becoming a new force in the field of diabetes treatment with its profound accumulation and unremitting innovation in the field of medicine.

Founded in 2004, Ruiming Pharmaceutical is located in No. 1558 Longjiang North Road, Chunjiang Town, Xinbei District, Changzhou City, Jiangsu Province, with a superior geographical position, close to the Yangtze River and Shanghai-Nanjing Expressway, convenient transportation and beautiful environment. The company covers an area of 25,000 square meters and has nine main buildings including three chemical synthesis workshops, a GMP-compliant refining and drying workshop, as well as complete material storage and production facilities. These hardware facilities provide a solid foundation for the company's efficient production and quality control.

Ruiming Pharmaceutical always applies GMP standards throughout every step of production and quality management to ensure the safety and effectiveness of products. So far, the company has passed the domestic GMP inspection of three apis, namely propafenone hydrochloride, Felodipine and amlodipine besylate, among which amlodipine besylate has obtained the EOQM CEP certificate, and successfully passed the European Union and Japan PMDA field audit, fully proving its product quality and international recognition.

In the field of diabetes treatment, Ruiming Pharmaceutical follows the forefront of the industry, focusing on scientific and technological research and development and technological innovation. The company has introduced a group of outstanding talents and established close cooperative relations with China Pharmaceutical University and Shanghai universities, and is committed to the research and development of diabetes treatment drugs. Through continuous technological research and innovation, Ruiming Pharmaceutical has achieved remarkable results in the treatment of diabetes drugs.

It is worth mentioning that Ruiming Pharmaceutical's new hypoglycemic drug has entered the clinical trial stage, which not only has excellent hypoglycemic effect, but also may play an important role in reducing side effects and improving the quality of life of patients. This breakthrough will undoubtedly bring new hope to diabetes patients around the world.

Looking forward to the future, Ruiming Pharmaceutical will continue to adhere to the concept of "science and technology and innovation", continue to increase research and development investment, and promote the development process of diabetes treatment drugs. At the same time, the company is also looking forward to establishing closer cooperation with customers and partners around the world, exploring more possibilities together, and contributing more strength to the cause of human health.

Sincerely welcome customers from all over the world to contact with the company to explore cooperation opportunities and seek honest development. Changzhou Ruiming Pharmaceutical is willing to work with you hand in hand to create a better future!